Novo allocates 1.3 billion Danish kroner for diabetes prevention and treatment in lower-income countries
Source ↗
👁 2
💬 0
Danish drugmaker Novo Nordisk has allocated $200 million to the World Diabetes Foundation to support diabetes prevention and treatment in low- and middle-income countries. The grant, worth more than 1.3 billion Danish kroner, will be distributed from 2027 through 2036, the company said in a statement Wednesday. Diabetes is a chronic disease in which the […]
Comments (0)